These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1818294)

  • 1. IL6 and lymphoproliferative disorders.
    Brouet JC; Levy Y
    Nouv Rev Fr Hematol (1978); 1991; 33(6):433-6. PubMed ID: 1818294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [IL 6 and lymphoproliferative diseases].
    Lévy Y; Brouet JC
    C R Seances Soc Biol Fil; 1991; 185(5):262-7. PubMed ID: 1806185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo models for studying the role of autocrine or paracrine growth factors in hematologic malignancies.
    Soma T; Dunbar CE
    Exp Hematol; 1995 May; 23(5):385-8. PubMed ID: 7720810
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-6 in autoimmune disorders.
    Yoshizaki K; Kuritani T; Kishimoto T
    Semin Immunol; 1992 Jun; 4(3):155-66. PubMed ID: 1627787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interleukin 6 and lymphoplasmocytic proliferation].
    Brouet JC; Lévy Y
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):225-6. PubMed ID: 8337132
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biology of interleukin-6. Role in lymphoplasmacytic hemopathies].
    Levy Y; Brouet JC
    Ann Med Interne (Paris); 1992; 143(8):533-43. PubMed ID: 1303597
    [No Abstract]   [Full Text] [Related]  

  • 7. [B lymphoproliferative syndrome with characteristics common to chronic lymphatic leukemia, Waldenström disease and plasmacytic leukemia].
    Tosato F; Fossaluzza V; Sala P; Tonutti E
    Minerva Med; 1984 Nov; 75(44):2691-4. PubMed ID: 6440066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
    Levy Y; Tsapis A; Brouet JC
    J Clin Invest; 1991 Aug; 88(2):696-9. PubMed ID: 1864979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases.
    Cesarman E; Knowles DM
    Semin Cancer Biol; 1999 Jun; 9(3):165-74. PubMed ID: 10343068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and roles of IL-6, IL-10, and IL-13 in B-lymphocyte malignancies and in B-lymphocyte hyperactivity of HIV infection and autoimmunity.
    Emilie D; Zou W; Fior R; Llorente L; Durandy A; Crevon MC; Maillot MC; Durand-Gasselin I; Raphael M; Peuchmaur M; Galamaud P
    Methods; 1997 Jan; 11(1):133-42. PubMed ID: 8990099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular involvement in lymphoproliferative disorders with hyperproduction of cytokines (Castleman, POEMS).
    Rieu P; Noël LH; Droz D; Beaufils H; Gessain A; Hermine O; Lesavre P
    Adv Nephrol Necker Hosp; 2000; 30():305-31. PubMed ID: 11068649
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy.
    van Rhee F; Stone K; Szmania S; Barlogie B; Singh Z
    Clin Adv Hematol Oncol; 2010 Jul; 8(7):486-98. PubMed ID: 20864917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and proteomics in multiple myeloma and Waldenström macroglobulinemia.
    Henry T; Fonseca R
    Curr Opin Hematol; 2007 Jul; 14(4):369-74. PubMed ID: 17534163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
    Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
    J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Membrane markers in chronic lymphoproliferative diseases].
    Matutes E; San Miguel JF; Catovsky D
    Med Clin (Barc); 1983 Mar; 80(7):334-50. PubMed ID: 6406774
    [No Abstract]   [Full Text] [Related]  

  • 18. Apoptotic resistance exhibited by dexamethasone-resistant murine 7TD1 cells is controlled independently of interleukin-6 triggered signaling.
    Gangavarapu KJ; Olbertz JL; Bhushan A; Lai JC; Daniels CK
    Apoptosis; 2008 Nov; 13(11):1394-400. PubMed ID: 18819004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lung involvement in lymphoid and lympho-plasmocytic proliferations (except lymphomas)].
    Uzunhan Y; Cadranel J; Boissel N; Gardin C; Arnulf B; Bergeron A
    Rev Mal Respir; 2010 Jun; 27(6):599-610. PubMed ID: 20610075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Castleman's disease.
    Palestro G; Turrini F; Pagano M; Chiusa L
    Adv Clin Path; 1999; 3(1-2):11-22. PubMed ID: 10655569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.